Aventria Health Group

How to Create a Groundswell to Activate Stakeholders and Increase Rare Disease Awareness

Raising awareness and interest in a disease area that is not top of mind is a common problem for the marketing of brands for rare diseases.

Aventria Health Group

Medicare Advantage Growth = Opportunities for Pharma to Support Patient Care

The Centers for Medicare & Medicaid Services (CMS) is transforming payment, delivery, and care in Medicare Advantage (MA) policies.

Aventria Health Group

Best Practices ≠ Most Practices, and Patients Pay the Price

Care gaps. Behavioral change. Suboptimal knowledge and care. Access challenges. Attention and time deficits.

Aventria Health Group

Do You See Impact in Customer Collaborations?

Effective customer collaborations can deliver great value, such as improved patient outcomes, satisfaction, appropriate use, and care delive

Aventria Health Group

Are Your Account Managers Prepared for Successful Selling to Health Systems/IDNs?

Discover how to elevate your brand’s performance with a winning health system/IDN engagement strategy with help from Aventria® Health Group.

Aventria Health Group

Have You Prioritized the Right Health System/IDN to Drive Brand Performance?

Pharmaceutical brand, payer marketing, market access, and managed markets teams—is senior management confident in your health system...

Aventria Health Group

Is Senior Management Confident in Your Brand’s Health System/IDN Performance?

Brand, payer marketing, market access, and managed markets teams: Now that you’ve concluded your brand’s 2020 business plans and finalized

Aventria Health Group

5 Pharma Brand Growth Myths: Impediments at Large Provider Customers (IDNs, LGPs, etc)

It’s not often that we hear pharma clients communicate high satisfaction with their KAM approach and sales performance, and that’s to be...

Aventria Health Group

Can Pharma and Health Systems Collaborate?

The number of pharmaceutical sales representatives has declined nationwide from about 120,000 to around 70,000. Meanwhile...

Blog Archive